SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

HIKAL informs about disclosure

29 Dec 2023 Evaluate
In continuation of earlier disclosure dated 15th December 2023, HIKAL has informed that the Company has received a letter dated 20th December 2023 from Gujarat Pollution Control Board (GPCB) directing the Company to pay Rs. 1745 lacs as per the recommendations made in the report submitted by the Joint Committee to NGT, New Delhi. The said letter dated 20.12.2023 was received by the Company on 28.12.2023. The Company, in consultation with its legal advisors, has taken steps towards appropriate legal remedies, which will be actioned and updated once the Court vacations are over. 

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

192.15 3.60 (1.91%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×